Wendy Guy is CAO at Processa Pharmaceuticals, Inc. (PCSA). They have made 7 open-market trades across 1 company since 2026, most recently 2026-06-30.
CIK 0001799360
7 open-market purchases totalling $33K since 2026, never a sale. Across 7 scored buys the stock is down 22.2% at ninety days, and 27.1 points behind the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| PCSA | 14,394 | $24K |
Shares reported on the most recent Form 4, priced at the 2026-07-01 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 14% | 29% | 0% |
| Avg Move | -4.7% | -9.2% | -22.2% |
| Alpha | -5.1% | -12.2% | -27.1% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PCSA | BUY | 2026-06-30 | 2026-07-01 | $1.93 | $5K | +7.5% | +0.9% | -14.6% |
| PCSA | BUY | 2026-06-15 | 2026-06-16 | $2.22 | $5K | -7.5% | +5.7% | -10.4% |
| PCSA | BUY | 2026-05-29 | 2026-06-01 | $2.57 | $5K | -6.2% | -23.7% | -20.6% |
| PCSA | BUY | 2026-05-15 | 2026-05-19 | $2.97 | $5K | -2.7% | -18.4% | -18.0% |
| PCSA | BUY | 2026-04-30 | 2026-05-01 | $2.69 | $5K | -6.6% | -7.3% | -25.5% |
| PCSA | BUY | 2026-04-15 | 2026-04-17 | $2.97 | $5K | -17.2% | -16.9% | -32.3% |
| PCSA | BUY | 2026-03-31 | 2026-04-01 | $2.54 | $5K | +0.0% | -4.5% | -34.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.